Roivant Sciences Ltd.
NASDAQ:ROIV
Overview | Financials
Company Name | Roivant Sciences Ltd. |
Symbol | ROIV |
Currency | USD |
Price | 11.76 |
Market Cap | 8,696,778,720 |
Dividend Yield | 0% |
52-week-range | 8.465 - 13.055 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Matthew Gline |
Website | https://roivant.com |
An error occurred while fetching data.
About Roivant Sciences Ltd.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD